Karen A Kalita
CIK 1778734 · Lihat di SEC EDGAR ↗
Pengajuan SEC Pertama: 4 Juni 2019 · Terbaru: 16 Juni 2026
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 10 Mei 2024 | CBT | S | 13.764 | $101,73 | $1.400.212 | 34.312 Langsung | -28,63% | Dilepas | -16,1% (harga per 2026-08-21) |
| 21 Nov. 2023 | CBT | S | 22.574 | $77,78 | $1.755.806 | 35.167 Langsung | -39,10% | Dilepas | 9,7% (harga per 2026-08-21) |
| 6 Juni 2022 | CBT | S | 4.575 | $78,13 | $357.445 | 25.874 Langsung | -15,03% | Dilepas | 9,2% (harga per 2026-08-21) |
| 10 Mei 2021 | CBT | S | 5.224 | $62,97 | $328.955 | 16.828 Langsung | -23,69% | Dilepas | 35,5% (harga per 2026-08-21) |
| 10 Mei 2021 | CBT | S | 5.533 | $62,72 | $347.030 | 16.154 Langsung | -25,51% | Dilepas | 36,0% (harga per 2026-08-21) |
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 12 Juni 2026 | CBT | Phantom Stock Units | Common Stock (28) | — | — | 28 | Diakuisisi |
| 13 Maret 2026 | CBT | Phantom Stock Units | Common Stock (34) | — | — | 34 | Diakuisisi |
| 31 Des. 2025 | CBT | Phantom Stock Units | Common Stock (922) | — | — | 922 | Diakuisisi |
| 12 Des. 2025 | CBT | Phantom Stock Units | Common Stock (28) | — | — | 28 | Diakuisisi |
| 19 Nov. 2025 | CBT | Employee Stock Option (Right to Buy) | Common Stock (16.908) | $59,76 | 18 Nov. 2035 | 16.908 | Diakuisisi |
| 30 Sep. 2025 | CBT | Phantom Stock Units | Common Stock (73) | — | — | 73 | Diakuisisi |
| 11 Sep. 2025 | CBT | Phantom Stock Units | Common Stock (23) | — | — | 23 | Diakuisisi |
| 13 Juni 2025 | CBT | Phantom Stock Units | Common Stock (25) | — | — | 25 | Diakuisisi |
| 14 Maret 2025 | CBT | Phantom Stock Units | Common Stock (21) | — | — | 21 | Diakuisisi |
| 31 Des. 2024 | CBT | Phantom Stock Units | Common Stock (713) | — | — | 713 | Diakuisisi |
| 13 Des. 2024 | CBT | Phantom Stock Units | Common Stock (14) | — | — | 14 | Diakuisisi |
| 8 Nov. 2024 | CBT | Employee Stock Option (Right to Buy) | Common Stock (6.616) | $114,99 | 7 Nov. 2034 | 6.616 | Diakuisisi |
| 30 Sep. 2024 | CBT | Phantom Stock Units | Common Stock (40) | — | — | 40 | Diakuisisi |
| 13 Sep. 2024 | CBT | Phantom Stock Units | Common Stock (14) | — | — | 14 | Diakuisisi |
| 14 Juni 2024 | CBT | Phantom Stock Units | Common Stock (15) | — | — | 15 | Diakuisisi |
| 10 Mei 2024 | CBT | Employee Stock Option (Right to Buy) | Common Stock (13.764) | $50,23 | 7 Nov. 2029 | 13.764 | Dilepas |
| 8 Maret 2024 | CBT | Phantom Stock Units | Common Stock (15) | — | — | 15 | Diakuisisi |
| 29 Des. 2023 | CBT | Phantom Stock Units | Common Stock (508) | — | — | 508 | Diakuisisi |
| 8 Des. 2023 | CBT | Phantom Stock Units | Common Stock (15) | — | — | 15 | Diakuisisi |
| 21 Nov. 2023 | CBT | Employee Stock Option (Right to Buy) | Common Stock (22.574) | $40,97 | 12 Nov. 2030 | 22.574 | Dilepas |
| 10 Nov. 2023 | CBT | Employee Stock Option (Right to Buy) | Common Stock (10.211) | $74,40 | 9 Nov. 2033 | 10.211 | Diakuisisi |
| 29 Sep. 2023 | CBT | Phantom Stock Units | Common Stock (60) | — | — | 60 | Diakuisisi |
| 8 Sep. 2023 | CBT | Phantom Stock Units | Common Stock (16) | — | — | 16 | Diakuisisi |
| 9 Juni 2023 | CBT | Phantom Stock Units | Common Stock (15) | — | — | 15 | Diakuisisi |
| 10 Maret 2023 | CBT | Phantom Stock Units | Common Stock (14) | — | — | 14 | Diakuisisi |
| 30 Des. 2022 | CBT | Phantom Stock Units | Common Stock (818) | — | — | 818 | Diakuisisi |
| 9 Des. 2022 | CBT | Phantom Stock Units | Common Stock (10) | — | — | 10 | Diakuisisi |
| 11 Nov. 2022 | CBT | Employee Stock Option (Right to Buy) | Common Stock (9.988) | $73,84 | 10 Nov. 2032 | 9.988 | Diakuisisi |
| 30 Sep. 2022 | CBT | Phantom Stock Units | Common Stock (51) | — | — | 51 | Diakuisisi |
| 9 Sep. 2022 | CBT | Phantom Stock Units | Common Stock (9) | — | — | 9 | Diakuisisi |
| 10 Juni 2022 | CBT | Phantom Stock | Common Stock (9) | — | — | 9 | Diakuisisi |
| 6 Juni 2022 | CBT | Employee Stock Options (Right to Buy) | Common Stock (4.575) | $40,91 | 2 Juni 2029 | 4.575 | Dilepas |
| 11 Maret 2022 | CBT | Phantom Stock | Common Stock (10) | — | — | 10 | Diakuisisi |
| 31 Des. 2021 | CBT | Phantom Stock Units | Common Stock (1.065) | — | — | 1.065 | Diakuisisi |
| 10 Des. 2021 | CBT | Phantom Stock Units | Common Stock (5) | — | — | 5 | Diakuisisi |
| 12 Nov. 2021 | CBT | Employee Stock Option (Right to Buy) | Common Stock (14.263) | $58,27 | 11 Nov. 2031 | 14.263 | Diakuisisi |
| 30 Sep. 2021 | CBT | Phantom Stock Units | Common Stock (44) | — | — | 44 | Diakuisisi |
| 10 Sep. 2021 | CBT | Phantom Stock Units | Common Stock (5) | — | — | 5 | Diakuisisi |
| 11 Juni 2021 | CBT | Phantom Stock Units | Common Stock (4) | — | — | 4 | Diakuisisi |
| 10 Mei 2021 | CBT | Stock Options | Common Stock (5.898) | $50,23 | 7 Nov. 2029 | 5.898 | Diakuisisi |
| 10 Mei 2021 | CBT | Stock Options | Common Stock (6.862) | $40,91 | 2 Juni 2029 | 6.862 | Diakuisisi |
| 12 Maret 2021 | CBT | Phantom Stock | Common Stock (5) | — | — | 5 | Diakuisisi |
| 31 Des. 2020 | CBT | Phantom Stock Units | Common Stock (131) | — | — | 131 | Diakuisisi |
| 11 Des. 2020 | CBT | Phantom Stock | Common Stock (5) | — | — | 5 | Diakuisisi |
| 13 Nov. 2020 | CBT | Employee Stock Option (Right to Buy) | Common Stock (22.574) | $40,97 | 12 Nov. 2030 | 22.574 | Diakuisisi |
| 11 Sep. 2020 | CBT | Phantom Stock | Common Stock (5) | — | — | 5 | Diakuisisi |
| 12 Juni 2020 | CBT | Phantom Stock | Common Stock (6) | — | — | 6 | Diakuisisi |
| 13 Maret 2020 | CBT | Phantom Stock | Common Stock (6) | — | — | 6 | Diakuisisi |
| 31 Des. 2019 | CBT | Phantom Stock Units | Common Stock (235) | — | — | 235 | Diakuisisi |
| 13 Des. 2019 | CBT | Phantom Stock | Common Stock (2) | — | — | 2 | Diakuisisi |
| 8 Nov. 2019 | CBT | Employee Stock Option (Right to Buy) | Common Stock (19.662) | $50,23 | 7 Nov. 2029 | 19.662 | Diakuisisi |
| 13 Sep. 2019 | CBT | Phantom Stock | Common Stock (2) | — | — | 2 | Diakuisisi |
| 14 Juni 2019 | CBT | Phantom Stock | Common Stock (3) | — | — | 3 | Diakuisisi |
| 3 Juni 2019 | CBT | Employee Stock Option (Right to Buy) | Common Stock (11.437) | $40,91 | 2 Juni 2029 | 11.437 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 3 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
CBT
General Counsel| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $496.662 | — | $487.417 | $262.495 | $287.161 | $1.040 | $95.927 | $1.630.702 |
| 2022 | $453.300 | — | $422.457 | $227.495 | $422.052 | $1.240 | $104.139 | $1.630.683 |
| 2021 | $412.499 | — | $406.218 | $218.697 | $461.189 | $1.780 | $97.086 | $1.597.469 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.